Robert Main , PA-C
Physician Assistant - Medical • Ocala, FL
3143 Sw 32nd Ave Ste 200
Ocala, FL 344744404
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
Robert Main is listed in NPPES under Physician Assistant - Medical.
-
NPI assigned on June 7, 2006; this date does not establish years in practice.
-
Published CMS data list 1,616 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Levothyroxine Sodium — 92 prescription fills, including refills.
- Atorvastatin Calcium — 90 prescription fills, including refills.
- Rosuvastatin Calcium — 79 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 60 records in the table · Guide: How to read Medicare Part D prescriber data
-
More Part D prescriptions than 65% of clinicians listed under Physician Assistant - Medical in Ocala, FL (2024, 13 clinicians with data). Median for this group: 273. Middle half: 116 to 3,033.
More Part D prescriptions than 80% of clinicians listed under Physician Assistant - Medical in Florida (2024, 1,293 clinicians with data). Median for this group: 401. Middle half: 110 to 1,206.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part D prescriptions went from 6,249 in 2020 to 1,616 in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2020–2024.
Practice Location & Contact Primary Location
3143 Sw 32nd Ave Ste 200
Ocala, FL 344744404
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
What Public CMS Data Show
Physician Assistant - Medical: NPPES taxonomy is a reported classification, not proof of board certification.
30-day fills
2,827 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$118,473 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $1,757.94 across 51 records.
By nature of payment
- Food and Beverage: $1,757.94 across 51 records.
Reporting-company totals (3 largest of 16)
- Bristol Myers Squibb Company: $301.34 across 3 records.
- Otsuka America Pharmaceutical, Inc.: $283.63 across 8 records.
- ABBVIE INC.: $250.00 across 2 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
NPI first issued
2006
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Medicare assignment not listed
CMS data do not show whether this clinician accepts Medicare assignment. This does not mean they do not accept Medicare. Ask the office.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Can order Medicare-covered services
CMS lists Robert Main as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Ocala and Florida
Billing and prescribing volume is not a quality rating.
Medicare Part D prescriptions
More Part D prescriptions than 65% of clinicians listed under Physician Assistant - Medical in Ocala, FL (2024, 13 clinicians with data). Median for this group: 273. Middle half: 116 to 3,033.
More Part D prescriptions than 80% of clinicians listed under Physician Assistant - Medical in Florida (2024, 1,293 clinicians with data). Median for this group: 401. Middle half: 110 to 1,206.
Part D drug cost
A higher Part D drug cost than 75% of clinicians listed under Physician Assistant - Medical in Ocala, FL (2024, 13 clinicians with data). Median for this group: $5,804. Middle half: $1,974 to $118,473.
A higher Part D drug cost than 70% of clinicians listed under Physician Assistant - Medical in Florida (2024, 1,293 clinicians with data). Median for this group: $13,592. Middle half: $1,260 to $125,527.
25 active clinicians are listed under Physician Assistant - Medical with a practice address in Ocala, FL (2,778 in Florida).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Ocala
4% of these 25 clinicians have the CMS telehealth indicator.
48% of these 25 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part D prescriptions
Medicare Part D prescriptions decreased 74% from 6,249 in 2020 to 1,616 in 2024.
- 2020: 6,249
- 2021: 6,704
- 2022: 6,259
- 2023: 7,188
- 2024: 1,616
-
30-day fills
30-day fills decreased 72% from 10,200 in 2020 to 2,827 in 2024.
- 2020: 10,200
- 2021: 10,844
- 2022: 10,576
- 2023: 12,277
- 2024: 2,827
-
Part D drug cost
Part D drug cost decreased 71% from $409,785 in 2020 to $118,473 in 2024.
- 2020: $409,785
- 2021: $676,684
- 2022: $593,477
- 2023: $811,873
- 2024: $118,473
-
Industry payments (Open Payments)
Industry payments (Open Payments) decreased 36% from $2,764.90 in 2021 to $1,757.94 in 2025.
- 2021: $2,764.90
- 2022: $2,009.35
- 2023: $1,369.47
- 2024: $2,672.21
- 2025: $1,757.94
Sources: CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 51 records totaling $1,757.94.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Novo Nordisk Inc |
Food and Beverage
In-kind items and services
|
Ozempic | General | $125.00 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
QULIPTA | General | $125.00 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
QULIPTA | General | $125.00 |
| Boehringer Ingelheim Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
OFEV | General | $121.69 |
| Bristol Myers Squibb Company |
Food and Beverage
Cash or cash equivalent
|
ZEPOSIA | General | $108.65 |
| Otsuka America Pharmaceutical, Inc. |
Food and Beverage
In-kind items and services
|
REXULTI | General | $105.24 |
| Otsuka America Pharmaceutical, Inc. |
Food and Beverage
In-kind items and services
|
REXULTI | General | $104.86 |
| Bristol Myers Squibb Company |
Food and Beverage
Cash or cash equivalent
|
ZEPOSIA | General | $102.00 |
| Bristol Myers Squibb Company |
Food and Beverage
Cash or cash equivalent
|
ZEPOSIA | General | $90.69 |
| Eisai Inc. |
Food and Beverage
Cash or cash equivalent
|
Leqembi | General | $65.59 |
| Amgen Inc. |
Food and Beverage
In-kind items and services
|
REPATHA | General | $60.47 |
| REVANCE THERAPEUTICS, INC. |
Food and Beverage
In-kind items and services
|
DAXXIFY | General | $40.63 |
| Amgen Inc. |
Food and Beverage
In-kind items and services
|
OTEZLA | General | $25.11 |
| Eisai Inc. |
Food and Beverage
In-kind items and services
|
Leqembi | General | $25.04 |
| Solta Medical, a division of Bausch Health US, LLC |
Food and Beverage
In-kind items and services
|
Clear & Brilliant | General | $24.48 |
| Amgen Inc. |
Food and Beverage
In-kind items and services
|
EVENITY | General | $22.58 |
| Otsuka America Pharmaceutical, Inc. |
Food and Beverage
In-kind items and services
|
REXULTI | General | $21.80 |
| Corcept Therapeutics |
Food and Beverage
In-kind items and services
|
Korlym | General | $21.57 |
| Eli Lilly and Company |
Food and Beverage
In-kind items and services
|
ZEPBOUND | General | $20.03 |
| Eisai Inc. |
Food and Beverage
In-kind items and services
|
Leqembi | General | $19.68 |
| Amgen Inc. |
Food and Beverage
In-kind items and services
|
REPATHA | General | $19.25 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
AIRSUPRA | General | $18.81 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
AIRSUPRA | General | $18.63 |
| Novo Nordisk Inc |
Food and Beverage
In-kind items and services
|
Rybelsus | General | $18.43 |
| Novo Nordisk Inc |
Food and Beverage
In-kind items and services
|
Ozempic | General | $18.24 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Levothyroxine Sodium | Levothyroxine Sodium | 92 | 5,890 | $666.93 | 36 |
| Atorvastatin Calcium | Atorvastatin Calcium | 90 | 5,986 | $410.08 | 38 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 79 | 6,330 | $765.38 | 35 |
| Fluticasone Propionate | Fluticasone Propionate | 74 | 2,550 | $709.59 | 18 |
| Losartan Potassium | Losartan Potassium | 52 | 3,360 | $428.65 | 24 |
| Gabapentin | Gabapentin | 50 | 1,827 | $569.15 | 16 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 49 | 1,915 | $498.42 | 19 |
| Alprazolam | Alprazolam | 47 | 1,410 | $271.23 | 16 |
| Methylprednisolone | Methylprednisolone | 40 | 240 | $379.57 | 24 |
| Lisinopril | Lisinopril | 37 | 2,400 | $161.90 | 17 |
| Metoprolol Tartrate | Metoprolol Tartrate | 36 | 2,730 | $270.20 | 19 |
| Omeprazole | Omeprazole | 36 | 2,161 | $381.17 | 19 |
| Ezetimibe | Ezetimibe | 36 | 2,754 | $241.43 | 18 |
| Hydrochlorothiazide | Hydrochlorothiazide | 35 | 3,030 | $121.45 | 18 |
| Amlodipine Besylate | Amlodipine Besylate | 34 | 2,590 | $187.43 | 21 |
| Clonazepam | Clonazepam | 31 | 930 | $497.84 | — |
| Azithromycin | Azithromycin | 28 | 140 | $79.58 | 24 |
| Risperidone | Risperidone | 28 | 840 | $315.41 | — |
| Ozempic | Semaglutide | 28 | 960 | $25,551.96 | — |
| Montelukast Sodium | Montelukast Sodium | 26 | 1,620 | $134.41 | 13 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 26 | 688 | $271.88 | — |
| Metoprolol Succinate | Metoprolol Succinate | 25 | 1,530 | $295.19 | 12 |
| Potassium Chloride | Potassium Chloride | 24 | 1,236 | $354.05 | — |
| Famotidine | Famotidine | 24 | 1,290 | $330.51 | 13 |
| Metformin Hcl Er | Metformin Hcl | 24 | 1,729 | $162.23 | 11 |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2024-04-23NUCC Taxonomy Code: 363AM0700X
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSSources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Registered at 3143 SW 32ND AVE STE 200, OCALA, FL 344744404 (Tel: 3522820010)
Registered at 3143 SW 32ND AVE STE 200, OCALA, FL 344744404 (Tel: 3522820010)
NPI status registered as active in NPPES database
Registered at 10762 SE US HIGHWAY 441, BELLEVIEW, FL 344203805 (Tel: 3523475225)
Registered at 10762 SE US HIGHWAY 441, BELLEVIEW, FL 344203805 (Tel: 3523475225)
Recorded as ROBERT MAIN, PA-C
Physician Assistant (license number reported to NPPES: FL PA9102762)
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Physician Assistant - Medicals in Ocala
- Stacey Schmidt, PA-C
- David Pabst, PA-C
- Luciana Oran, PA-C
- Vinh Nguyen, PA
- Lori Dupere
- Frank Kolovrat
Mailing Address
3143 Sw 32nd Ave Ste 200
Ocala, FL 344744404
Phone: 3522820010